{"nct_id":"NCT03303313","title":"A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome","status":"WITHDRAWN","status_verified_date":"2018-09","start_date":"2017-09-19","start_date_type":"ACTUAL","primary_completion_date":"2018-09-12","primary_completion_date_type":"ACTUAL","completion_date":"2018-09-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ALNY"]}